Wang, Dennis D.
Naumova, Anna V.
Isquith, Daniel
Sapp, Jamie
Huynh, Kim A.
Tucker, Isabella
Balu, Niranjan
Voronyuk, Anna
Chu, Baocheng
Ordovas, Karen
Maynard, Charles
Tian, Rong
Zhao, Xue-Qiao
Kim, Francis
Funding for this research was provided by:
U.S. Department of Veterans Affairs (1IK2BX006111-01A1)
AstraZeneca (ESR 17-13124)
National Institutes of Health (R01HL157261, R01HL157261)
Article History
Received: 19 March 2024
Accepted: 3 June 2024
First Online: 7 June 2024
Declarations
:
: a. The trial was approved by the Institutional Review Board at the University of Washington.
: b. All authors approve the manuscript and give their consent for submission and publication.
: The authors declare no competing interests.